FibroGen, Inc. (FGEN)
| Market Cap | 1.86B |
| Revenue (ttm) | 176.32M |
| Net Income (ttm) | -189.29M |
| Shares Out | 89.85M |
| EPS (ttm) | -2.11 |
| PE Ratio | n/a |
| Forward PE | 61.35 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 7 |
| Last Price | $20.23 |
| Previous Close | $20.64 |
| Change ($) | -0.41 |
| Change (%) | -1.99% |
| Day's Open | 20.85 |
| Day's Range | 20.10 - 21.22 |
| Day's Volume | 686,958 |
| 52-Week Range | 18.12 - 57.21 |
Boston, Massachusetts--(Newsfile Corp. - May 8, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of FibroGen, Inc. (NASDAQ: FGEN). The cas...
San Francisco, California--(Newsfile Corp. - May 7, 2021) - Hagens Berman urges FibroGen, Inc. (NASDAQ: FGEN) investors with significant losses to submit your losses now.Class Period: Oct. 18, 2017 - A...
San Francisco, California--(Newsfile Corp. - May 7, 2021) - On April 12, 2021, Berman Tabacco filed a class action lawsuit for violations of the federal securities laws against FibroGen, Inc. ("FibroGe...
FibroGen (FGEN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
New Orleans, Louisiana--(Newsfile Corp. - May 6, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until...
NEW YORK, May 6, 2021 /PRNewswire/ -- Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP ("BLB&G") filed a class action lawsuit for violations of the federal securities ...
Los Angeles, California--(Newsfile Corp. - May 6, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FibroGen, Inc. ("FibroGe...
Radnor, Pennsylvania--(Newsfile Corp. - May 6, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against FibroGen, ...
Boston, Massachusetts--(Newsfile Corp. - May 6, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of FibroGen, Inc. (NASDAQ: FGEN). The cas...
New York, New York--(Newsfile Corp. - May 6, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of FibroGen, Inc..Shareholders who pur...
New York, New York--(Newsfile Corp. - May 5, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of FibroGen, Inc. (NASDAQ: FGEN) between November 8, 201...
New York, New York--(Newsfile Corp. - May 5, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased FibroGen, Inc. ("Fibro...
RADNOR, Pa., May 5, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against FibroGen, Inc. (NASDAQ: ...
New York, New York--(Newsfile Corp. - May 5, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of FibroG...
New York, New York--(Newsfile Corp. - May 5, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against FibroGen, Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN) and certain of...
LOS ANGELES, May 5, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming June 11, 2021 deadline to file a lead plaintiff motion in the class action filed on beha...
Los Angeles, California--(Newsfile Corp. - May 5, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FibroGen, Inc. ("FibroGe...
New York, New York--(Newsfile Corp. - May 5, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of FibroGen, Inc. (NASDAQ: FGEN) alleging that th...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In FibroGen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor...
Radnor, Pennsylvania--(Newsfile Corp. - May 4, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of FibroGen, Inc. (NASDAQ: FGEN) ("FibroGen") that a securities fraud class ac...
New York, New York--(Newsfile Corp. - May 4, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of FibroGen, Inc.Shareholders who purc...
Los Angeles, California--(Newsfile Corp. - May 4, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FibroGen, Inc. ("FibroGe...
New York, New York--(Newsfile Corp. - May 3, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased FibroGen, Inc. ("Fibro...
Boston, Massachusetts--(Newsfile Corp. - May 3, 2021) - Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces that a lawsuit for violations of the federal securiti...
Los Angeles, California--(Newsfile Corp. - May 3, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FibroGen, Inc. ("FibroGe...
NEW YORK, May 1, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against FibroGen, Inc. ("FibroGen" or the "Company") (NASDAQ: FGEN) and certain of its officers. ...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In FibroGen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor...
RADNOR, Pa., April 30, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of FibroGen, Inc. (NASDAQ: FGEN) ("FibroGen") that a securities fraud class action lawsui...
Los Angeles, California--(Newsfile Corp. - April 30, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FibroGen, Inc. ("Fibr...
New York, New York--(Newsfile Corp. - April 30, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securi...
SAN FRANCISCO--(BUSINESS WIRE)-- #Fibrogen--FIBROGEN SHAREHOLDERS: June 11, 2021 Filing Deadline in Class Action – Contact Lieff Cabraser
New Orleans, Louisiana--(Newsfile Corp. - April 29, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have un...
FibroGen (FGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
San Francisco, California--(Newsfile Corp. - April 29, 2021) - Hagens Berman urges FibroGen, Inc. (NASDAQ: FGEN) investors with significant losses to submit your losses now. Class Period: Nov. 8, 2019 -...
New York, New York--(Newsfile Corp. - April 29, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Fib...
Los Angeles, California--(Newsfile Corp. - April 29, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FibroGen, Inc. (NASDA...
Philadelphia, Pennsylvania--(Newsfile Corp. - April 29, 2021) - Berger Montague is investigating potential securities fraud claims against FibroGen, Inc. ("FibroGen" or the "Company") on behalf of inves...
New York, New York--(Newsfile Corp. - April 28, 2021) - Pomerantz LLP is investigating claims on behalf of investors of FibroGen, Inc. ("FibroGen" or the "Company")(NASDAQ: FGEN). Such investors are adv...
Radnor, Pennsylvania--(Newsfile Corp. - April 28, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against FibroGe...
New York, New York--(Newsfile Corp. - April 28, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of FibroGen, Inc..Shareholders who ...
Boston, Massachusetts--(Newsfile Corp. - April 28, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of FibroGen, Inc. (NASDAQ: FGEN). The ...
New York, New York--(Newsfile Corp. - April 28, 2021) - Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders FibroGen, Inc. (NASDAQ: FGEN).CLICK ...
Los Angeles, California--(Newsfile Corp. - April 28, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FibroGen, Inc. ("Fibr...
New York, New York--(Newsfile Corp. - April 28, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased FibroGen, Inc. ("Fi...
Boston, Massachusetts--(Newsfile Corp. - April 28, 2021) - Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces that a lawsuit for violations of the federal secur...
SAN FRANCISCO, April 28, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) announced that Enrique Conterno, Chief Executive Officer, will participate in a fireside chat at the BofA Securities 2021 ...
New York, New York--(Newsfile Corp. - April 28, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of FibroGen, Inc. (NASDAQ: FGEN) alleging that...
New York, New York--(Newsfile Corp. - April 27, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Fib...
Los Angeles, California--(Newsfile Corp. - April 27, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FibroGen, Inc. ("Fibr...
NEW YORK, April 26, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of FibroGen, Inc. ("FibroGen" or the "Company")(NASDAQ: FGEN). Such investors are advised to contac...
About FGEN
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases that is in Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States and Europe; and in Phase II/III development in China for anemia associated with myelodysplastic syndromes. It is also developing Pamrevlumab, a human monoclonal antibody that inh... [Read more...]
| Industry Biotechnology | IPO Date Nov 14, 2014 |
| CEO Enrique Conterno | Employees 599 |
| Stock Exchange NASDAQ | Ticker Symbol FGEN |
Financial Performance
In 2020, FibroGen's revenue was $176.32 million, a decrease of -31.28% compared to the previous year's $256.58 million. Losses were -$189.29 million, 145.9% more than in 2019.
Analyst Forecasts
According to 10 analysts, the average rating for FibroGen stock is "Buy." The 12-month stock price forecast is 40.57, which is an increase of 100.54% from the latest price.